EU advises on use of Lilly’s Covid-19 antibody cocktail

BRUSSELS: Europe’s medicines regulator said on Friday Eli Lilly and Co’s antibody drug combination can be used to treat Covid-19 patients who do not require oxygen support and are at high risk of progressing to severe illness.

The recommendation can now be used as guidance in individual European nations on the possible use of the combination of bamlanivimab and etesevimab, before a broader approval is given, the European Medicines Agency (EMA) said.

To continue reading please click here

Leave a Reply

Related Articles

Back to top button